{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:32:22Z","timestamp":1793370742063,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.diagmicrobio.2021.115572","type":"journal-article","created":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T20:03:35Z","timestamp":1633982615000},"page":"115572","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["A brief history of OspA vaccines including their impact on diagnostic testing for Lyme disease"],"prefix":"10.1016","volume":"102","author":[{"given":"Gary P.","family":"Wormser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0001","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/439524a","article-title":"Lyme disease: uphill struggle","volume":"439","author":"Abbott","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0002","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1128\/JCM.37.11.3718-3721.1999","article-title":"Effects of OspA vaccination on Lyme disease serologic testing","volume":"37","author":"Aguero-Rosenfeld","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0003","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1468-0009.2012.00663.x","article-title":"The rise and fall of the Lyme disease vaccines: a cautionary tale for risk interventions in American medicine and public health","volume":"90","author":"Aronowitz","year":"2012","journal-title":"The Milbank Quarterly"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0004","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1586\/14760584.2013.824704","article-title":"A novel multivalent OspA vaccine against Lyme borreliosis shows promise in phase I\/II studies","volume":"12","author":"Barrett","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0005","article-title":"Mice against ticks: an experimental community guided effort to prevent tick-borne disease by altering the shared environment","volume":"B 374","author":"Buchthal","year":"2019","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2021.115572_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113294","article-title":"Design and development of a novel vaccine for protection against Lyme borreliosis","volume":"9","author":"Comstedt","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0007","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1128\/IAI.67.1.30-35.1999","article-title":"Influence of outer surface protein A on Borrelia burgdorferi within feeding ticks","volume":"67","author":"De Silva","year":"1999","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2021.115572_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.ttbdis.2021.101649","article-title":"Control of ixodid ticks and prevention of tick-borne diseases in the United States: the prospect of a new Lyme disease vaccine and the continuing problem with tick exposure on residential properties","volume":"12","author":"Eisen","year":"2021","journal-title":"Ticks Tick Borne Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0009","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13071-015-0676-x","article-title":"Immunization with a recombinant subunit OspA vaccine markedly impacts the rate of newly acquired Borrelia burgdorferi infections in client-owned dogs living in a coastal community in Maine, USA","volume":"8","author":"Eschner","year":"2015","journal-title":"Parasites & Vectors"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0010","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1021\/acs.bioconjchem.9b00167","article-title":"Antigen engineering approaches for Lyme disease vaccines","volume":"30","author":"Federizon","year":"2019","journal-title":"Bioconjugate Chem"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0011","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/infdis\/164.6.1224","article-title":"Protection of mice from Lyme borreliosis by oral vaccination with Escherichia coli expressing OspA","volume":"164","author":"Fikrig","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0012","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.4049\/jimmunol.148.7.2256","article-title":"Borrelia burgdorferi strain 25015: characterization of outer surface protein A and vaccination against infection","volume":"148","author":"Fikrig","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0013","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1073\/pnas.89.12.5418","article-title":"Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice","volume":"89","author":"Fikrig","year":"1992","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0014","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1128\/IAI.73.3.1644-1647.2005","article-title":"Interactions of OspA monoclonal antibody C3.78 with Borrelia burgdorferi within ticks","volume":"73","author":"Gipson","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0015","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/cid\/ciz872","article-title":"Protective immunity and new vaccines for Lyme disease","volume":"70","author":"Gomes-Solecki","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0016","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1126\/science.281.5377.703","article-title":"Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis","volume":"281","author":"Gross","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0017","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/21645515.2015.1087628","article-title":"Vaccination against Lyme disease: Are we ready for it?","volume":"12","author":"Kaaijk","year":"2016","journal-title":"Human Vaccines Immunotherapeutics"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0018","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3201\/eid2702.202731","article-title":"Estimating the frequency of Lyme disease diagnoses United States, 2010-2018","volume":"27","author":"Kugeler","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0019","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0264-410X(01)00500-X","article-title":"Adverse event reports following vaccination for Lyme disease: December 1998-July 2000","volume":"20","author":"Lathrop","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0020","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1939-1676.2006.tb02880.x","article-title":"ACVIM small animal consensus statement on Lyme disease in dogs: diagnosis, treatment, and prevention","volume":"20","author":"Littman","year":"2006","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0021","article-title":"VANGUARDcrLyme: A next generation Lyme disease vaccine that prevents B. burgdorferi infection in dogs","volume":"6","author":"Marconi","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0022","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1128\/JCM.40.7.2591-2593.2002","article-title":"Evaluation of the C6 peptide enzyme-linked immunosorbent assay for individuals vaccinated with the recombinant OspA vaccine","volume":"40","author":"Marques","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0023","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1056\/NEJM200107123450201","article-title":"Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite","volume":"345","author":"Nadelman","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0024","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2217\/fmb.09.17","article-title":"Human Lyme disease vaccines: past and future concerns","volume":"4","author":"Nardelli","year":"2009","journal-title":"Future Microbiol"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0025","doi-asserted-by":"crossref","first-page":"e00917","DOI":"10.1128\/IAI.00917-19","article-title":"Broadly protective multivalent OspA vaccine against Lyme borreliosis, developed based on surface shaping of the C-terminal fragment","volume":"88","author":"Nayak","year":"2020","journal-title":"Infect Immun"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0950268806007096","article-title":"The Lyme vaccine, a cautionary tale","volume":"135","author":"Nigrovic","year":"2007","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0027","first-page":"191","article-title":"Human and veterinary vaccines for Lyme disease","volume":"42","author":"O'Bier","year":"2021","journal-title":"Curr Issues Mol Biol"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2021.115572_bib0028","doi-asserted-by":"crossref","first-page":"ofab142","DOI":"10.1093\/ofid\/ofab142","article-title":"Clinical effectiveness of Lyme vaccine: a matched case-control study","volume":"8","author":"Oliveira","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"Suppl 3","key":"10.1016\/j.diagmicrobio.2021.115572_bib0029","doi-asserted-by":"crossref","first-page":"s271","DOI":"10.1093\/cid\/ciq119","article-title":"Correcting a public health fiasco: the need for a new vaccine against Lyme disease","volume":"52","author":"Plotkin","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0030","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1093\/infdis\/jiu005","article-title":"Reservoir targeted vaccine against Borrelia burgdorferi: a new strategy to prevent Lyme disease","volume":"209","author":"Richer","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.pt.2010.06.006","article-title":"Lyme borreliosis vaccination: the facts, the challenge, the future","volume":"27","author":"Schuijt","year":"2011","journal-title":"Trends Parasitology"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0032","doi-asserted-by":"crossref","first-page":"19214","DOI":"10.1073\/pnas.1913923116","article-title":"Lyme disease vaccines face familiar challenges, both societal and scientific","volume":"116","author":"Shaffer","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0033","doi-asserted-by":"crossref","first-page":"S247","DOI":"10.1093\/cid\/ciq115","article-title":"The Lyme disease vaccine: a public health perspective","volume":"52","author":"Shen","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0034","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1056\/NEJM199807233390402","article-title":"A vaccine consisting of recombinant Borrelia burgdorferi outer surface protein A to prevent Lyme disease","volume":"339","author":"Sigal","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0035","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/art.10772","article-title":"Binding of outer surface protein A and human lymphocyte function-associated 1 peptides to HLA-DR molecules associated with antibiotic treatment-resistant Lyme arthritis","volume":"48","author":"Steere","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0036","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM199807233390401","article-title":"Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant","volume":"339","author":"Steere","year":"1998","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2021.115572_bib0037","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3390\/vaccines8030463","article-title":"Proteomic as an exploratory approach to develop vaccines against tick-borne diseases using Lyme borreliosis as a test case","volume":"8","author":"Talagrand-Reboul","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0038","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.4049\/jimmunol.166.8.5286","article-title":"Molecular mimicry in Lyme arthritis demonstrated at the single cell level: LFA-1\u03b1 is a partial agonist for outer-surface protein A-reactive T cells","volume":"166","author":"Trollmo","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0039","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1089\/vbz.2012.1003","article-title":"Reductions in human Lyme disease risk due to the effects of oral vaccination on tick-to-mouse and mouse-to-tick transmission","volume":"13","author":"Voordouw","year":"2013","journal-title":"Vector-Borne Zoonotic Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0040","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/clinids\/21.5.1267","article-title":"Prospects for a vaccine to prevent Lyme disease in humans","volume":"21","author":"Wormser","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0041","doi-asserted-by":"crossref","first-page":"627","DOI":"10.7326\/0003-4819-123-8-199510150-00011","article-title":"A vaccine against Lyme disease?","volume":"123","author":"Wormser","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0042","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF01713340","article-title":"Lyme disease vaccines","volume":"24","author":"Wormser","year":"1996","journal-title":"Infection"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0043","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0891-5520(05)70047-7","article-title":"Vaccination as a modality to prevent Lyme disease a status report","volume":"13","author":"Wormser","year":"1999","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0044","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1128\/CVI.00406-14","article-title":"A novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi sensu lato","volume":"21","author":"Wressnigg","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.diagmicrobio.2021.115572_bib0045","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S1473-3099(13)70110-5","article-title":"Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomized, dose-escalation phase 1\/2 trial","volume":"13","author":"Wressnigg","year":"2013","journal-title":"Lancet Infect Dis"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889321002649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889321002649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:56:41Z","timestamp":1760003801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889321002649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0732889321002649"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2021.115572","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A brief history of OspA vaccines including their impact on diagnostic testing for Lyme disease","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2021.115572","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115572"}}